Navigation Links
Vital step in cellular migration described by UCSD medical researchers

A vital molecular step in cell migration, the movement of cells within the body during growth, tissue repair and the body's immune response to invading pathogens, has been demonstrated by researchers in the University of California, San Diego (UCSD) School of Medicine. Published in the March 27 online edition of Nature Cell Biology and the journal's upcoming April print edition, the study describes how a the interaction of alpha4 integrin adhesion receptor with a protein called paxillin creates directional movement of a cell by inhibiting a protein called Rac.

"Understanding how this protein contributes to directional movement of a cell provides a new insight into cell migration and ultimately could lead to therapeutic interventions in autoimmune diseases such as multiple sclerosis and Crohn's disease," said the paper's first author Naoyuki Nishiya, Ph.D., a postgraduate researcher in the lab of senior author Mark Ginsberg, M.D., UCSD professor of medicine. "Since cell migration plays an important role in the immune response, as leukocytes move toward targets, a therapy that stops that movement could potentially help in autoimmune disorders where the body's immune system incorrectly attacks the body's own tissue."

From the genesis of human life to birth and beyond, cell migration is a complex, extremely important process that is not completely understood by researchers. In order to move, a cell must be polarized so that the molecular processes at the front end and back end are different, leading only to forward movement. One of the first steps in cell migration is the initiation of activity by Rac that extends protrusions out of the cell. These protrusions serve as tractor sites for migration as the cell moves toward its intended target. If Rac were active throughout the cell, it would extend protrusions in all directions, in essence keeping the cell in one place.

Until now, researchers have had limited understanding of the molecular mechanism that inhibits Rac activity in the back of the cell, to maintain directional movement. In laboratory experiments with human and animal cells, the UCSD team discovered that the alpha4 integrin recruits enzymes that block Rac activity only at the rear of a crawling cell.

The scientists noted that alpha4 integrins are widely expressed in neural crest cells, immune system leukocytes (such as T cells), striated and smooth muscle, and neurons. For this reason, they believe the mechanism used by alpha4 integrins to localize Rac activity may participate in a wide variety of cell migratory and pathfinding events.

In addition to Nishiya and Ginsberg, additional authors were William B. Kiosses, Ph.D., The Scripps Research Institute, La Jolla, California; and Jaewon Han, Ph.D., UCSD Department of Medicine. The study was funded by the National Institutes of Health.


'"/>

Source:University of California - San Diego


Related biology news :

1. Vital ocean prey play active role in environment
2. Scientists discover the cellular roots of graying hair
3. MSI releases moleculizer - a new approach to simulation of intracellular biochemical networks
4. New study to explore cellular circuitry
5. Study provides insight into cellular defenses against genetic mutation
6. Carnegie Mellon develops non-invasive technique to detect transplant rejection at cellular level
7. Liver cancer linked to cellular repair pathway
8. New cellular flaw found in some virulent breast cancers
9. Insects that produce males from unfertilized eggs reveal a surprising cellular feat
10. University of Minnesota researchers take new look at cellular suicide
11. RNA found in the cellular centrosome of surf clams
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/14/2019)... ... January 14, 2019 , ... CellMax Life , a ... blood, will present new findings at the ASCO Gastrointestinal Cancer Symposium in San ... results from this study show CellMax Life’s blood test, based on its proprietary ...
(Date:1/10/2019)... ... January 10, 2019 , ... ... translational gap between inexpensive in vitro studies and significantly more expensive in vivo ... vivo efficacy and toxicity. To address this need, researchers have begun to adopt ...
(Date:1/7/2019)... (PRWEB) , ... January 07, 2019 , ... ... (RWD) and Artificial Intelligence solutions for precision health in oncology and other key ... J.P Morgan’s exclusive meeting of investors, entrepreneurs and executives spanning the entire healthcare ...
Breaking Biology News(10 mins):
(Date:1/20/2019)... ... January 16, 2019 , ... On January 15 of this year, ... by Asymmetrex director James L. Sherley, M.D., Ph.D. The PGCB was ... the PGCB and CellTrials.org. Now in its 21st year of operation, the PGCB ...
(Date:1/20/2019)... LOUISVILLE, Ky. (PRWEB) , ... January 17, 2019 ... ... and an Autodesk Platinum Partner announces the launch of a specialized automation technology, ... customer requested parameters for automatic generation of models and drawings to deliver to ...
(Date:1/15/2019)... ... January 15, 2019 , ... With the U.S. Congress designating January as Cervical ... (STD) testing service, today announces tips to help reduce the risk of Cervical Cancer. , ... (HPV). Genital HPV is the #1 most common STD and an STI that ...
(Date:1/10/2019)... ... 2019 , ... Rascal was adopted from a local shelter when he was around two years ... Unfortunately, just six weeks after he was adopted, he tore his right cruciate ligament. ... the joint after such a traumatic injury. , Sure enough, when Rascal was about nine ...
Breaking Biology Technology: